SKYE
Skye Bioscience, Inc.
1.70$
-1.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +1,992.8% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +2,352.2% | – | – | +49.9% | -46.1% | -80.8% | -5.3% | +28.0% | +1,723.2% | +236.9% | +8.0% | +140.4% | +142.2% | |
| – | +1,815.9% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +153.2% | +63.0% | -66.8% | +6.0% | +577.6% | -13.1% | +50.8% | +105.1% | -3.2% | +221.4% | +126.5% | |
| – | +1,789.0% | +1,979.7% | +49.4% | -5.6% | +0.5% | +23.0% | +0.7% | -1.1% | +13.1% | +24.0% | +28.8% | +125.7% | -10.9% | |
| – | +3,088.0% | +1,165.8% | +58.0% | +3.6% | -13.7% | +21.6% | +41.3% | -5.2% | +24.8% | +133.3% | +89.7% | -13.1% | +90.2% | |
| – | -275.9% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +237.1% | – | – | -100.0% | – | +14,107.3% | +956.0% | -29.4% | +8.7% | -13.5% | +36.5% | +6.8% | -100.0% | |
| – | -179.5% | – | – | – | – | – | – | -722.9% | – | – | – | – | – | |
| – | -1,506.5% | – | -31.5% | -6.8% | +0.0% | +2.6% | -2.6% | +0.0% | +31.3% | +221.0% | -46.6% | +179.8% | -46.4% | |
| – | -2,770.3% | – | – | – | – | – | – | -723.7% | – | – | – | – | – | |
| – | +94.3% | – | – | – | – | – | – | -386.4% | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.